Dichlorphenamide Patent Expiration

Dichlorphenamide was first introduced by Xeris Pharmaceuticals Inc in its drug Daranide on Approved Prior to Jan 1, 1982. Another drug containing Dichlorphenamide is Keveyis. 3 different companies have introduced drugs containing Dichlorphenamide.


Dichlorphenamide Patents

Given below is the list of patents protecting Dichlorphenamide, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Keveyis US12758502 Compositions And Methods Of Use Dec 23, 2043 Xeris



Dichlorphenamide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Dichlorphenamide Generic API Manufacturers

Several generic applications have been filed for Dichlorphenamide. The first generic version for Dichlorphenamide was by Torrent Pharma Inc and was approved on Dec 29, 2022. And the latest generic version is by Rising Pharma Holdings Inc and was approved on Nov 18, 2025.

Given below is the list of companies who have filed for Dichlorphenamide generic, along with the locations of their manufacturing plants worldwide.